Hair Loss Blood Tests: What to Expect Before, During & After

Introduction: Why Blood Tests Are a Critical First Step in Hair Loss Diagnosis

Hair loss affects an estimated 85% of men and 33% of women at some point in their lives, making it one of the most common medical concerns worldwide. By age 35, approximately 40 to 65 percent of men show noticeable hair loss, and the condition impacts more than 56 million people globally.

Yet millions of patients receive blood test results labeled “normal” while continuing to lose hair. This disconnect exists because standard laboratory reference ranges are designed for general population health, not follicular function. What passes as statistically acceptable for the average person may be suboptimal for the metabolically demanding environment of hair follicles.

This article addresses three core scenarios: diagnostic blood testing for unexplained hair loss, gender-specific panels with particular attention to women’s needs, and pre-surgical blood work required before a hair transplant. Readers will learn what each test measures, what results actually mean for hair health, and what distinguishes a clinically meaningful panel from a cursory one.

Not all hair loss requires blood testing. Routine male or female pattern baldness may be diagnosed clinically through physical examination and patient history alone. However, diffuse shedding, rapid progression, or systemic symptoms warrant laboratory investigation. The diagnostic philosophy at practices like Shapiro Medical Group emphasizes deliberate, targeted testing guided by clinical presentation rather than reflexive broad panels.

When Should You Get Blood Tests for Hair Loss?

Shedding 50 to 100 hairs per day is normal. Blood tests become relevant when shedding exceeds 100 to 150 hairs per day, visible thinning appears, or bald patches develop.

Clinical triggers that prompt a physician to order blood work include:

• Diffuse or sudden shedding (telogen effluvium)
• Female pattern hair loss
• Suspected nutritional deficiency
• Thyroid symptoms
• Hormonal irregularities
• Autoimmune conditions
• Rapid unexplained progression

Androgenetic alopecia, the typical male or female pattern baldness, is often diagnosed through physical examination and patient history alone. Blood tests are not always the first step for these presentations.

According to guidance from the American Academy of Dermatology, blood tests or scalp biopsy may be ordered when a disease, vitamin deficiency, hormone imbalance, or infection is suspected as the underlying cause.

Blood tests represent one tool within a broader diagnostic framework that also includes scalp examination, trichoscopy, pull test, and sometimes scalp biopsy. No single test tells the whole story. The process is straightforward, and the information gained can reveal correctable causes of hair loss that, once treated, may significantly improve or halt shedding.

The “Lab Normal vs. Hair-Optimal” Gap: Why Passing a Standard Blood Test Doesn’t Mean Your Hair Is Getting What It Needs

Laboratory reference ranges are derived from large population studies and represent statistical norms for general health. They are not calibrated to the specific metabolic demands of hair follicles.

Ferritin provides the primary example. Standard lab “normal” for ferritin can be as low as 12 to 15 ng/mL in many laboratories. Yet clinical evidence suggests ferritin above 70 ng/mL is needed to support healthy hair growth cycles.

The same logic applies to thyroid markers. A TSH reading of 4.0 mIU/L may fall within the standard lab range of 0.5 to 5.0 mIU/L. However, emerging evidence and specialist practice suggest TSH between 0.5 and 2.5 mIU/L is more optimal for hair follicle function.

This gap exists because reference ranges are set to flag serious disease, not to optimize tissue-level function in metabolically active structures like hair follicles.

A landmark 2026 study published in JAAD International analyzed 22.8 million laboratory results and found that broad, indiscriminate lab testing for telogen effluvium may be “fruitless and unnecessarily costly.” This reinforces that thoughtful, clinically guided testing outperforms blanket panels.

A 2025 cross-sectional study of 23,975 patients found that hair loss patients had slightly lower zinc and ferritin than controls, but differences were within normal ranges. This illustrates exactly why nuanced interpretation matters more than a simple pass/fail reading.

The Core Blood Panel for Hair Loss: What Each Test Measures and Why It Matters

The following represents a clinician-guided tour through the most diagnostically valuable tests. This is not an exhaustive list of every possible marker but a targeted panel built around the most common and correctable causes of hair loss.

Complete Blood Count (CBC)

A CBC measures red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. Its relevance to hair loss lies in anemia detection. Low hemoglobin or hematocrit reduces oxygen delivery to hair follicles, pushing them into the resting (telogen) phase prematurely.

CBC also screens for infections and inflammatory conditions that can trigger autoimmune hair loss. However, CBC alone is insufficient for iron assessment. Serum ferritin is the more sensitive marker and must be ordered separately.

Iron Studies and Serum Ferritin

Ferritin is the most sensitive marker for iron deficiency affecting hair. Low ferritin is one of the most common and reversible causes of hair loss.

The hair-optimal threshold is ferritin above 70 ng/mL, compared to standard lab normals that may accept values as low as 12 to 15 ng/mL. Ferritin measures stored iron in the body, providing a more reliable indicator of iron status than serum iron alone, which fluctuates with recent dietary intake.

A 2025 study of 120 women found a significant decline in ferritin levels in women with hair loss compared to healthy controls. Importantly, iron deficiency can coexist with normal hemoglobin. A patient can have depleted iron stores without being clinically anemic yet still experience significant hair shedding.

Thyroid Function: TSH, Free T3, and Free T4

Both hypothyroidism (elevated TSH) and hyperthyroidism (suppressed TSH) disrupt the hair growth cycle and cause diffuse shedding. Thyroid dysfunction is estimated to affect up to 20% of hair loss patients.

TSH is the primary screening test, while Free T3 and Free T4 provide a more complete picture of active thyroid hormone levels. A TSH within the broad standard range may still be suboptimal for follicular function; specialist interpretation considers the full clinical picture.

Postpartum thyroiditis is a frequently missed cause of hair shedding after delivery, relevant for the 30 to 50 percent of women who experience postpartum telogen effluvium. Thyroid-related hair loss is typically diffuse and reversible once thyroid levels are normalized with appropriate treatment.

Vitamin D

Vitamin D plays a role in keratinocyte differentiation and the activation of hair follicle stem cells. Levels under 30 ng/mL are linked to alopecia and impaired hair growth cycle function.

The 2025 study of 120 women also found a significant decline in vitamin D levels in women with hair loss compared to healthy controls. Vitamin D deficiency is extremely common and often asymptomatic, making it an important routine check in hair loss workups.

Vitamin B12 and Folate

B12 and folate are essential for DNA synthesis and cell division, processes critical in the rapidly dividing cells of hair follicles. B12 deficiency can cause premature graying and thinning, in addition to neurological symptoms.

Folate and B12 work synergistically. Deficiency in one can mask or exacerbate deficiency in the other, making it important to test both together. Certain medications, such as metformin and proton pump inhibitors, can deplete B12. Vegans, vegetarians, and older adults are at higher risk of B12 deficiency and may warrant more frequent monitoring.

Zinc

Zinc serves as an essential cofactor for enzymes in the hair follicle and functions in inhibiting follicular apoptosis (programmed cell death). However, serum zinc measurement presents complexity. The body tightly regulates serum zinc levels, so blood tests may not accurately reflect tissue-level zinc status.

The 2025 cross-sectional study of 23,975 patients found hair loss patients had slightly lower zinc levels than controls, but differences were statistically minor and within normal ranges. Excessive zinc supplementation can induce copper deficiency, which itself can worsen hair loss. This illustrates the importance of clinician-guided supplementation rather than self-treatment.

Inflammatory Markers: CRP, ESR, and ANA

C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) serve as general markers of systemic inflammation. Elevated levels may point to autoimmune or inflammatory conditions driving hair loss.

Antinuclear antibody (ANA) testing can indicate autoimmune conditions such as lupus, which can cause scarring alopecia or diffuse hair loss. Alopecia areata, an autoimmune condition causing patchy hair loss, may be associated with elevated inflammatory markers.

A positive ANA alone is not diagnostic. It must be interpreted alongside clinical findings and may prompt referral to a rheumatologist. Identifying an autoimmune basis for hair loss changes the treatment approach significantly, shifting from nutritional correction to immunomodulatory therapy.

Cortisol

Elevated cortisol reflects chronic physiological or psychological stress, which can push hair follicles prematurely into the telogen phase. This condition is known as telogen effluvium.

Cortisol testing is not part of every hair loss panel. It is ordered when the clinical history suggests significant stress as a contributing factor. According to NIH StatPearls, approximately 70% of anagen (growing) hairs can shift to telogen under significant physiological stress.

Cortisol levels fluctuate throughout the day (diurnal variation), so timing of the blood draw matters. Morning samples are typically most informative. Stress-induced hair loss is generally reversible once the underlying stressor is addressed.

Sex Hormones: Testosterone, DHEA-S, and Related Markers

Androgens, particularly dihydrotestosterone (DHT), testosterone, and DHEA-S, are the primary hormonal drivers of androgenetic alopecia in both men and women.

Total and free testosterone reflect overall androgen burden. DHEA-S indicates adrenal androgen production. Sex hormone-binding globulin (SHBG) determines how much testosterone is biologically active. Prolactin, LH, and FSH may also be ordered to assess pituitary function and rule out hormonal disorders.

In men, hormonal panels are typically ordered when other causes have been ruled out or when additional symptoms suggest endocrine dysfunction. Androgenetic alopecia in men is usually a clinical diagnosis.

Hair Loss Blood Tests for Women: Why the Standard Panel Is Often Not Enough

Female hair loss is frequently misdiagnosed or inadequately investigated. Diffuse thinning in women is often mistakenly attributed to stress or aging when hormonal or nutritional causes are present. Research indicates that 52% of postmenopausal women experience female pattern baldness.

Women require a more expansive hormonal workup than men in most hair loss presentations. The standard male-oriented panel misses key female-specific drivers.

Androgens and PCOS: The Most Overlooked Driver of Female Hair Loss

Polycystic ovary syndrome (PCOS) is a leading cause of androgen excess in women and a significant driver of female pattern hair loss. Research published in the Journal of Clinical Endocrinology & Metabolism found that 38.5% of women with female pattern hair loss had elevated androgen levels.

The expanded panel for suspected androgen excess includes total testosterone, free testosterone, DHEA-S, androstenedione, SHBG, and fasting insulin or glucose to assess insulin resistance.

Oral contraceptives lower SHBG and can increase free androgen availability by approximately 20%, making medication history critical when interpreting hormonal results. Elevated androgens in women require a different treatment approach than simple androgenetic alopecia.

LH/FSH Ratio, Prolactin, and Thyroid in Women

An elevated LH-to-FSH ratio (greater than 2:1) is a common finding in PCOS and helps confirm the diagnosis alongside androgen levels and clinical symptoms. Elevated prolactin (hyperprolactinemia) can suppress ovarian function, reduce estrogen levels, and contribute to hair thinning.

A 2025 study of 2,851 female telogen effluvium patients confirmed that biochemical tests, CBC, and hormonal tests are important tools in investigating etiology and guiding treatment.

Interpreting Female Results in Context

Female hormonal results must be interpreted in the context of the menstrual cycle phase at the time of testing. Hormone levels fluctuate significantly across the cycle. The optimal time to test sex hormones in premenopausal women is typically days 2 to 5 of the menstrual cycle (early follicular phase) for the most accurate baseline reading.

A testosterone level at the high end of the female normal range may still be contributing to hair loss in a genetically susceptible individual. A comprehensive female hair loss workup integrates hormonal findings with clinical examination, trichoscopy, and patient history.

Pre-Hair Transplant Blood Tests: What You Need Before Surgery

Pre-surgical blood work serves a dual purpose: identifying any remaining correctable causes of hair loss that should be addressed before surgery, and assessing surgical safety to protect the patient during and after the procedure.

The global hair transplant market is projected to reach $10.51 billion in 2026 and grow to $21.46 billion by 2029. This scale of demand underscores why standardized pre-procedure evaluation protocols matter.

Surgical Safety Panel: The Tests Required Before a Hair Transplant

The required tests include:

• Complete Blood Count (CBC): Screens for anemia, infection, and platelet abnormalities affecting bleeding or healing
• Coagulation Profile (PT, APTT, bleeding time, clotting time): Assesses clotting ability, critical for scalp incisions and graft extraction
• Blood Glucose: Elevated glucose impairs wound healing and increases infection risk
• Liver Function Tests (LFTs): The liver metabolizes anesthetic agents and medications used during surgery
• Kidney Function (BUN/Creatinine): Affects fluid balance and medication excretion
• Infectious Disease Screening (HIV, HBsAg, HCV): Required for infection control protocols

Some patients may also require an electrocardiogram (ECG) or cardiovascular clearance depending on age and medical history.

How Pre-Surgical Results Shape the Treatment Plan

Abnormal pre-surgical results do not automatically disqualify a patient from a hair transplant. They inform how the procedure is planned and what precautions are taken.

A patient with borderline anemia may be advised to optimize iron levels before surgery. A patient with elevated glucose may need medical clearance from their primary care physician. Patients taking blood thinners or supplements affecting coagulation may be advised to pause them before surgery.

This pre-surgical diligence is part of what distinguishes a world-class hair restoration practice from a high-volume clinic. At Shapiro Medical Group, every detail is reviewed before a patient enters the surgical suite, consistent with the practice’s one-patient-per-day philosophy. Patients considering whether they are a good candidate can learn more about evaluating candidacy for a hair transplant before moving forward.

What to Expect Before, During, and After Your Blood Draw

Before the Blood Draw: Preparation Steps

Preparation requirements include:

• Fasting: Some tests require 8 to 12 hours of fasting; the ordering physician will specify which tests require this
• Medication disclosure: Provide a complete list of all medications and supplements, as many can influence results
• Timing for hormonal tests: Women should ideally have sex hormone panels drawn at days 2 to 5 of their menstrual cycle
• Hydration: Staying well-hydrated makes veins easier to access
• Cortisol timing: If cortisol is being tested, the draw is typically scheduled for the morning

During the Blood Draw: What Actually Happens

A phlebotomist or nurse will clean the skin over a vein (typically in the inner elbow), insert a small needle, and collect blood into one or more collection tubes. The process takes only a few minutes.

A comprehensive hair loss panel may require 3 to 5 tubes, which represents a small total volume of blood. Patients anxious about needles should communicate this to the phlebotomist, who can take additional steps to minimize discomfort. Minor bruising at the puncture site is the most common side effect.

After the Blood Draw: Waiting for Results and Next Steps

Most standard hair loss blood tests return results within a few days to a week. Some specialized hormone panels or autoimmune markers may take slightly longer.

Results are typically reviewed by the ordering physician before being shared with the patient. A follow-up consultation is usually scheduled to discuss findings in context rather than simply sending numbers without interpretation.

A result that appears “normal” on paper may still be clinically significant in the context of the patient’s symptoms, hair loss pattern, and other findings. Results may prompt additional testing. For example, a positive ANA may lead to further autoimmune workup, while low ferritin with normal CBC may prompt iron supplementation and a follow-up ferritin test in 3 to 6 months.

How Blood Test Results Shape Your Hair Loss Treatment Plan

The value of blood testing lies not in the tests themselves but in how findings are translated into a personalized treatment strategy.

Correctable deficiencies (iron, vitamin D, B12, thyroid) are addressed first, often through supplementation or medication, before or alongside hair restoration treatments. Hormonal findings in women may lead to referral to an endocrinologist or gynecologist for PCOS management or anti-androgen therapy. Autoimmune findings may redirect the treatment approach entirely.

After corrective treatment, levels should be rechecked at 3 to 6 months to confirm response before assessing hair regrowth outcomes. Blood tests inform not just what treatment to pursue but also the timing and sequencing. Optimizing nutritional status before a hair transplant improves surgical outcomes and recovery.

At Shapiro Medical Group, diagnostic findings are incorporated into a comprehensive treatment plan that may include medical therapies, regenerative treatments, and surgical options, all sequenced appropriately based on the patient’s complete clinical picture.

The SMG Diagnostic Philosophy: Targeted Testing Over Blanket Panels

Shapiro Medical Group’s approach to diagnostic testing is guided by clinical presentation, patient history, and the specific pattern of hair loss, not by ordering every available test regardless of relevance.

The 2026 JAAD International study analyzing 22.8 million laboratory results validated this approach, demonstrating that broad, indiscriminate testing for telogen effluvium may be “fruitless and unnecessarily costly.”

Targeted testing means fewer unnecessary tests, faster time to meaningful results, lower cost, and a clearer path to treatment without sacrificing diagnostic thoroughness. The one-patient-per-day policy ensures that each patient’s diagnostic workup receives focused attention. Results are reviewed in the full context of the individual patient, not processed in bulk.

With over 30 years of exclusive focus on hair restoration, SMG’s physicians know precisely which tests are most informative for a given clinical presentation. The diagnostic process is a starting point for a relationship, not a transaction.

Conclusion: Knowledge Is the Foundation of Effective Hair Loss Treatment

Blood tests are a powerful diagnostic tool when ordered thoughtfully and interpreted with clinical expertise. However, a “normal” result on a standard panel does not mean hair loss has no treatable cause.

The difference between a cursory panel and a clinically meaningful one can be the difference between continued hair loss and a clear path to recovery. This article has addressed diagnostic testing for unexplained hair loss, gender-specific panels (especially the expanded hormonal workup for women), and pre-surgical blood work for hair transplant candidates.

Seeking answers about hair loss takes courage. Understanding the diagnostic process is an important step toward feeling in control of the journey. Blood testing represents the beginning of a solution: identifying correctable causes, informing treatment sequencing, and ensuring surgical safety.

Ready to Get Answers? Schedule a Consultation with Shapiro Medical Group

Patients experiencing hair loss, whether just beginning to investigate causes or considering a hair transplant, are invited to schedule a consultation with Shapiro Medical Group.

The consultation includes a thorough clinical evaluation, discussion of whether and which blood tests are appropriate for the specific presentation, and a personalized treatment plan built around findings. SMG welcomes patients from across the United States and abroad, with established protocols to support those traveling to Minneapolis for care.

The one-patient-per-day commitment ensures every consultation receives the full, undivided attention of the SMG medical team. No rushed appointments. No assembly-line care.

Visit shapiromedical.com to request a consultation or contact the practice directly. Whether the answer lies in a nutritional correction, a hormonal treatment, a hair transplant, or a combination of approaches, Shapiro Medical Group has the expertise and diagnostic rigor to find it.